219 related articles for article (PubMed ID: 36528750)
1. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
2. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
3. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
4. Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone.
Hodgson K; Orozco-Moreno M; Goode EA; Fisher M; Garnham R; Beatson R; Turner H; Livermore K; Zhou Y; Wilson L; Visser EA; Pijnenborg JF; Eerden N; Moons SJ; Rossing E; Hysenaj G; Krishna R; Peng Z; Nangkana KP; Schmidt EN; Duxfield A; Dennis EP; Heer R; Lawson MA; Macauley M; Elliott DJ; Büll C; Scott E; Boltje TJ; Drake RR; Wang N; Munkley J
EBioMedicine; 2024 Jun; 104():105163. PubMed ID: 38772281
[TBL] [Abstract][Full Text] [Related]
5. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
Chen X; Wang L; Yu X; Wang S; Zhang J
Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
[TBL] [Abstract][Full Text] [Related]
7. ST6GAL1 and α2-6 Sialylation Regulates IL-6 Expression and Secretion in Chronic Obstructive Pulmonary Disease.
Krick S; Helton ES; Easter M; Bollenbecker S; Denson R; Zaharias R; Cochran P; Vang S; Harris E; Wells JM; Barnes JW
Front Immunol; 2021; 12():693149. PubMed ID: 34290711
[TBL] [Abstract][Full Text] [Related]
8. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma.
Zhao Y; Li Y; Ma H; Dong W; Zhou H; Song X; Zhang J; Jia L
Mol Cell Proteomics; 2014 Feb; 13(2):520-36. PubMed ID: 24255131
[TBL] [Abstract][Full Text] [Related]
9. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects.
Wang L; Chen X; Wang L; Wang S; Li W; Liu Y; Zhang J
IUBMB Life; 2021 Nov; 73(11):1378-1391. PubMed ID: 34559939
[TBL] [Abstract][Full Text] [Related]
11. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal1 in plasma is dispensable for IgG sialylation.
Oswald DM; Lehoux SD; Zhou JY; Glendenning LM; Cummings RD; Cobb BA
Glycobiology; 2022 Aug; 32(9):803-813. PubMed ID: 35746897
[TBL] [Abstract][Full Text] [Related]
13. Loss of core fucosylation in both ST6GAL1 and its substrate enhances glycoprotein sialylation in mice.
Huang G; Li Z; Li Y; Liu G; Sun S; Gu J; Kameyama A; Li W; Dong W
Biochem J; 2020 Mar; 477(6):1179-1201. PubMed ID: 32141499
[TBL] [Abstract][Full Text] [Related]
14. Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis.
Dall'Olio F; Chiricolo M; D'Errico A; Gruppioni E; Altimari A; Fiorentino M; Grigioni WF
Glycobiology; 2004 Jan; 14(1):39-49. PubMed ID: 14514712
[TBL] [Abstract][Full Text] [Related]
15. α2,6 Sialylation mediated by ST6GAL1 promotes glioblastoma growth.
Gc S; Tuy K; Rickenbacker L; Jones R; Chakraborty A; Miller CR; Beierle EA; Hanumanthu VS; Tran AN; Mobley JA; Bellis SL; Hjelmeland AB
JCI Insight; 2022 Nov; 7(21):. PubMed ID: 36345944
[TBL] [Abstract][Full Text] [Related]
16. The Inhibitory Role of α2,6-Sialylation in Adipogenesis.
Kaburagi T; Kizuka Y; Kitazume S; Taniguchi N
J Biol Chem; 2017 Feb; 292(6):2278-2286. PubMed ID: 28031460
[TBL] [Abstract][Full Text] [Related]
17. Platelet-localized ST6Gal1 does not impact IgG sialylation.
Glendenning LM; Zhou JY; Kukan EN; Gao C; Cummings RD; Joshi S; Whiteheart SW; Cobb BA
Glycobiology; 2023 Dec; 33(11):943-953. PubMed ID: 37379323
[TBL] [Abstract][Full Text] [Related]
18. Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels.
Lu J; Isaji T; Im S; Fukuda T; Kameyama A; Gu J
J Biol Chem; 2016 Mar; 291(11):5708-5720. PubMed ID: 26801611
[TBL] [Abstract][Full Text] [Related]
19. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of ST6GAL1 in the tumor progression of colorectal cancer.
Zhang S; Lu J; Xu Z; Zou X; Sun X; Xu Y; Shan A; Lu J; Yan X; Cui Y; Yan W; Du Y; Gu J; Zheng M; Feng B; Zhang Y
Biochem Biophys Res Commun; 2017 May; 486(4):1090-1096. PubMed ID: 28377225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
